You are here

Izotropic Corporation

Listing Exchange: 
CSE
Status: 
Active
Industry: 
Life Sciences
Symbol: 
IZO
CSE Index: 
Currency: 

The Company is engaged in the commercialization of proprietary diagnostic products for breast cancer. Its business strategy is to complete the commercial development of 360 degree, true 3D breast imaging technology for early diagnosis of breast cancer. The Company holds a license under a license agreement to make, have made, use, offer for sale, import, and sell products and services and to practice processes and methods in the field of human diagnostics and therapeutics in the United States and any other countries where approvals are granted or where patent rights may exist in the future with respect to certain licensed patent rights.

You are here

Izotropic Corporation (IZO)

SEDAR Information

Company Info

Address
800-15355 24 Avenue
Suite 424
Surrey, BC V4A 2H9
Canada
Phone
1-833-IZOCORP (496-2677)
Email
info@izocorp.com
Website
http://www.izocorp.com
Listing date
Thursday, May 31, 2018
Transfer Agent
Odyssey Trust Company
Investor Relations
Dan Sammartino
Email
IR@izocorp.com
Auditor
DMCL

Advertisement

Publicité

Capitalization

Issued & Outstanding: 
40,210,578
Reserved for Issuance: 
19,087,011

Bulletins

30/05/2018

2018-0529 – New Listing – Izotropic Corporation (IZO)

Le 30 mai/May 2018

The common shares of Izotropic Corporation have been approved for listing on the CSE.

Listing and disclosure documents will be available at www.thecse.com on the trading date.

Advertisement

Publicité

Latest CSE News

Upcoming Events